Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.
Some organisations have IP strategies in place, yet many businesses are still missing out on vital opportunities. This ...
8don MSN
This $200 Billion Streaming Giant Is Partnering With a Top AI Company (Hint: It's Not Nvidia)
Despite fears of a possible bubble bursting, artificial intelligence (AI) is a technology that increasingly looks like it's not going away. There are already businesses winning the AI race, whether ...
Explore proprietary technology. Learn about its types, benefits, and real-world examples to understand how it offers businesses a competitive advantage.
The UK has a chance to shape the next era of chip technology. The challenge is turning pockets of excellence into national ...
Opinion
7don MSNOpinion
President Trump Should Restore Crucial Trade Wins From His First Term | Opinion
The Trump administration now has the opportunity to finish the job it started in the first term on IP protection under the USMCA.
Canada’s innovation results are the worst of all. The Business Council of Alberta concluded that Canada’s innovation ...
XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the "Company" or "XTL"), announced today that it has received a notification letter from ...
Congress dropped a bipartisan provision from Pentagon spending legislation that would have given the military right to repair ...
The former chief executive of Nexperia, a Dutch chipmaker, said Dutch officials had known for years that the company’s Chinese owner sought to move its technology to China.
Opinion: IP rights holders who sue defendants under seal must show they've performed thorough due diligence to withstand growing scrutiny of "Schedule A" lawsuits.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results